Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...
Hosted on MSN
Machine learning helps tailor deep brain stimulation to improve gait in Parkinson’s disease
A team of researchers at the University of California, San Francisco has developed a data-driven method for optimizing deep brain stimulation (DBS) settings that significantly improved walking ...
Abbott announced that it received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation (DBS) device ...
CELLTech™ DBS is currently being developed in the United States in close collaboration with the FDA through the Early Feasibility Study (EFS) Program [FDA's EFS Program]. "It has been amazing to work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback